Skip to content

Long-Term Patient Satisfaction of Facial Aesthetic Treatment With BOTOX®

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01608672
Enrollment
207
Registered
2012-05-31
Start date
2012-04-01
Completion date
2012-12-31
Last updated
2019-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glabellar Lines

Brief summary

This is an observational study assessing patient satisfaction following at least 5 years of BOTOX® treatment for glabellar lines.

Interventions

BIOLOGICALbotulinum toxin Type A

botulinum toxin Type A (BOTOX®) treatment to glabellar lines as prescribed by the Investigator over at least 5 years.

Sponsors

Allergan
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* At least one BOTOX® treatment for facial wrinkles (glabellar lines) per calendar year for ≥5 years

Exclusion criteria

* Received botulinum toxin formulations other than BOTOX®

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Participants Mostly or Very Satisfied With Their Glabellar Lines on the Facial Line Satisfaction Questionnaire (FLSQ)Study Day 1 (approximately 4-28 weeks following last treatment)Participants assessed their overall satisfaction with their glabellar lines by answering FLSQ Question 5: How satisfied are you with the effect your treatment had on your facial lines? using a 5-point scale where: -2=very dissatisfied, -1=mostly dissatisfied, 0=neither dissatisfied nor satisfied, 1=mostly satisfied and 2=very satisfied. The percentage of participants mostly or very satisfied is reported.

Secondary

MeasureTime frameDescription
Percentage of Participants Mostly or Very Satisfied With Effectiveness of ≥ 5 Years BOTOX® Treatments Using the Patient QuestionnaireStudy Day 1 (approximately 4-28 weeks following last treatment)Participants rated their overall satisfaction with BOTOX® treatment by answering the question on the Patient Reported Overall Satisfaction of Effectiveness Questionnaire: You have received BOTOX® facial aesthetic treatment(s) for at least 5 years. How satisfied overall are you with the effect of BOTOX®? using the following possible answers: Very Dissatisfied, Mostly Dissatisfied, Neither Satisfied or Dissatisfied, Mostly Satisfied or Very Satisfied. The percentage of participants who answered Mostly Satisfied or Very Satisfied is reported.
Percentage of Participants Where Physician Was Mostly or Very Satisfied With Effectiveness of ≥ 5 Years BOTOX® Treatments Using the Physician QuestionnaireStudy Day 1 (approximately 4-28 weeks following last treatment)Physicians rated their overall satisfaction with BOTOX® treatment by answering the question on the Physician Reported Overall Satisfaction of Effectiveness Questionnaire: You have treated this patient with BOTOX® facial aesthetic treatment(s) for at least 5 years. How satisfied overall are you with the effect of BOTOX®? using the following possible answers: Very Dissatisfied, Mostly Dissatisfied, Neither Satisfied or Dissatisfied, Mostly Satisfied or Very Satisfied. The percentage of participants where the physician answered Mostly Satisfied or Very Satisfied is reported.

Countries

Australia, Brazil, Canada, France, United States

Participant flow

Pre-assignment details

Eligible patients were identified by retrospective chart review. Demographic and Outcome Measure data were collected at a study visit on Day 1 (approximately 4-28 weeks following last treatment) for patients who received treatment with BOTOX® for ≥5 years. Adverse Event data was collected by retrospective chart review.

Participants by arm

ArmCount
All Participants
Botulinum toxin Type A (BOTOX®) treatment to glabellar lines as prescribed by the Investigator over a period of at least 5 years.
207
Total207

Baseline characteristics

CharacteristicAll Participants
Age, Continuous55.6 years
STANDARD_DEVIATION 10.2
Sex: Female, Male
Female
194 Participants
Sex: Female, Male
Male
13 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
23 / 207
serious
Total, serious adverse events
0 / 207

Outcome results

Primary

Percentage of Participants Mostly or Very Satisfied With Their Glabellar Lines on the Facial Line Satisfaction Questionnaire (FLSQ)

Participants assessed their overall satisfaction with their glabellar lines by answering FLSQ Question 5: How satisfied are you with the effect your treatment had on your facial lines? using a 5-point scale where: -2=very dissatisfied, -1=mostly dissatisfied, 0=neither dissatisfied nor satisfied, 1=mostly satisfied and 2=very satisfied. The percentage of participants mostly or very satisfied is reported.

Time frame: Study Day 1 (approximately 4-28 weeks following last treatment)

Population: Per Protocol population included all enrolled participants who met eligibility criteria with data available for analysis.

ArmMeasureValue (NUMBER)
All ParticipantsPercentage of Participants Mostly or Very Satisfied With Their Glabellar Lines on the Facial Line Satisfaction Questionnaire (FLSQ)92.3 Percentage of participants
Secondary

Percentage of Participants Mostly or Very Satisfied With Effectiveness of ≥ 5 Years BOTOX® Treatments Using the Patient Questionnaire

Participants rated their overall satisfaction with BOTOX® treatment by answering the question on the Patient Reported Overall Satisfaction of Effectiveness Questionnaire: You have received BOTOX® facial aesthetic treatment(s) for at least 5 years. How satisfied overall are you with the effect of BOTOX®? using the following possible answers: Very Dissatisfied, Mostly Dissatisfied, Neither Satisfied or Dissatisfied, Mostly Satisfied or Very Satisfied. The percentage of participants who answered Mostly Satisfied or Very Satisfied is reported.

Time frame: Study Day 1 (approximately 4-28 weeks following last treatment)

Population: Per Protocol population included all enrolled participants who met eligibility criteria with data available for analysis.

ArmMeasureValue (NUMBER)
All ParticipantsPercentage of Participants Mostly or Very Satisfied With Effectiveness of ≥ 5 Years BOTOX® Treatments Using the Patient Questionnaire95.8 Percentage of participants
Secondary

Percentage of Participants Where Physician Was Mostly or Very Satisfied With Effectiveness of ≥ 5 Years BOTOX® Treatments Using the Physician Questionnaire

Physicians rated their overall satisfaction with BOTOX® treatment by answering the question on the Physician Reported Overall Satisfaction of Effectiveness Questionnaire: You have treated this patient with BOTOX® facial aesthetic treatment(s) for at least 5 years. How satisfied overall are you with the effect of BOTOX®? using the following possible answers: Very Dissatisfied, Mostly Dissatisfied, Neither Satisfied or Dissatisfied, Mostly Satisfied or Very Satisfied. The percentage of participants where the physician answered Mostly Satisfied or Very Satisfied is reported.

Time frame: Study Day 1 (approximately 4-28 weeks following last treatment)

Population: Per Protocol population included all enrolled participants who met eligibility criteria with data available for analysis.

ArmMeasureValue (NUMBER)
All ParticipantsPercentage of Participants Where Physician Was Mostly or Very Satisfied With Effectiveness of ≥ 5 Years BOTOX® Treatments Using the Physician Questionnaire98.0 Percentage of participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026